低强度激光照射促进伤口愈合

来源 :全国第二十三届烧伤专业委员会学术会议 | 被引量 : 0次 | 上传用户:langguoji
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
烧伤、创伤、整形术及其他原因所致的慢性创伤是临床上常见的组织损伤,一般修复迟缓,包括电击伤、药物性坏死、瘢痕及化学灼伤等引起的难愈性溃疡创面,常延至数月或数年不愈,成为现代外科学创伤修复领域的重要研究课题.因此,控制炎症,加速创伤后组织的修复过程始终是人们关心的问题.近年,激光技术的飞速发展为各种创面的治疗提供了新的手段,研究表明低强度激光疗法(low level laser therapy,LLLT)有生物刺激和调节作用,可用于治疗多种原因引起的炎症,促进损伤组织的修 复(1-7).
其他文献
目的 Tight regulation of the cell cycle in hematopoietic stem cells (HSCs) is essential for maintaining their lifelong self-renewal capacity.
会议
目的 Human cytomegalovirus (HCMV) infection is a common complication of allo-hematopoietic stem cell transplantation (allo-HSCT), which is associated with high morbidity and mortality.
会议
目的 FHL2, a member of the four and one half LIM domain protein family, is a critical transcriptionalmodulator.
会议
目的 Prolonged isolated thrombocytopenia (PIT) represents a significant complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and is associated with an adverse patient progn
会议
目的 观察G-CSF动员的半相合异基因外周造血干细胞输注联合化疗治疗恶性血液病的安全性.方法 17例恶性血液病患者在化疗结束24-48h内给予半相合异基因外周造血干细胞输注,共3疗程;12例急性髓系白血病患者,5例骨髓增生异常综合症患者;17例均为亲缘关系供者,其中12对供受者3个位点相合,5对为4个位点相合.
会议
目的 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for malignant hematological diseases, but prolonged isolated thrombocytopenia (PIT) following allo-HSCT seri
会议
目的 The advantages of using cord blood (CB) over bone marrow (BM) and mobilized peripheral blood as source of hematopoietic stem cell transplantation (HSCT) include easy availability, tolerance to huma
会议
目的 Acute graft-versus-host disease (aGVHD) is a major limitation of allogeneic hematopoietic stem cell transplantation (allo-HSCT).The mechanism of aGVHD has not been completely elucidated.
会议
目的 The clinical and prognostic significance of EVI1+ in AML patients receiving allo-HSCT has not been clearly identified方法 Here, we retrospectively examined EVI1 expression levels and clinical outcome
会议
目的 观察加大阿克拉霉素剂量的CAG方案治疗复发/难治混合表型急性白血病(MPAL)的疗效.方法 回顾性分析改良CAG方案治疗60例复发/难治MPAL (MPAL-1组)疗效及不良反应,同64例DOAP方案治疗组(MPAL-2组)、113例HD-CAG治疗复发/难治AML患者及78例HD-CAG治疗复发/难治ALL患者比较.
会议